Abstracts Archive - Page 2404 of 2607 - ACR Meeting Abstracts

Abstract Number: 410 • 2013 ACR/ARHP Annual Meeting
Correlation of Carotid Intima Media Thickness With Interleukin-6, Tumor Necrosis Factor-α and Anti-Cyclic Citrullinated Peptides In Rheumatoid Arthritis
Lourdes Nuñez Atahualpa¹, Mauricio Figuroa Sanchez¹, Daniel Alberto Rocha Muñoz², Raul Vargas Ramirez³, Beatriz Teresita Martin Marquez⁴, Jorge Ivan Gamez Nava⁵, Laura González López⁶, Erika Martínez García³, Esther Sanchez Corona³, Marcelo Petri⁴, Rosa Navarro Hernandez³, Veronica Gonzalez Diaz⁷, Jorge Aguilar Arreola⁸, Ana Guisllaine Bernard Medina⁹, Alejandra Nuñez Atahualpa¹⁰, Javier Andrade Garduño¹⁰, Eduardo Gomez Bañuelos³ and Monica Vazquez Del Mercado^4,8, ¹Radiology, Hospital Civil Fray Antonio Alcalde, Guadalajara, Mexico, ²Unidad de Investigación en Epidemiología Clínica del Hospital de Especialidades Centro Médico Nacional de Occidente, IMSS, Guadalajara, Jalisco, Mexico, ³CUCS, Universidad de Guadalajara, Instituto de Investigación en Reumatología y del Sistema Músculo Esquelético,, Guadalajara, Mexico, ⁴Instituto de Investigación en Reumatología y del Sistema Músculo Esquelético, Universidad de Guadalajara, Guadalajara, Mexico, ⁵Unidad de Investigación en Epidemiología Clínica, Hospital de Especialidades Centro Médico Nacional de Occidente., Guadalajara, Jalisco, Mexico, ⁶Medicina Interna-Reumatología, Departamento de Medicina Interna-Reumatología, Hospital General Regional 110, Instituto Mexicano del Seguro Social., Guadalajara, Jalisco, Mexico, ⁷Reumatologia, Antiguo Hospital Civil de Guadalajara - Fray Antonio Alcalde, Guadalajara, Mexico, ⁸Rheumatology, Hospital Civil Dr Juan I Menchaca, Guadalajara, Mexico, ⁹Rheumatology, Hospital Civil Fray Antonio Alcalde, Guadalajara, Mexico, ¹⁰Universidad Autónoma de Guadalajara, Guadalajara, Mexico
Background/Purpose: The main cause of death in rheumatoid arthritis patients are cardiovascular events which cannot be entirely explained by traditional risk factors, suggesting, that systemic…
Abstract Number: 411 • 2013 ACR/ARHP Annual Meeting
Differential Effects of biologics On The Removal Of Amyloid Deposition Between The Kidney and Gastric Tract Of Amyloid A Amyloidosis Patients With Rheumatoid Arthritis
Hiroshi Uda¹, Tamaki Harada², Ayumi Matsumoto³, Aya Mizumoto², Toshirou Takama² and Osamu Saiki¹, ¹Rheumatology, Higashiosaka City General Hospital, Higashiosaka, Japan, ²Nephrology, Higashiosaka City General Hospital, Higashiosaka, Japan, ³Higashiosaka City General Hospital, Higashiosaka, Japan
Background/Purpose: Several biologics therapy reportedly regress gastric amyloid deposition in amyloid A (AA) amyloidosis patients with rheumatoid arthritis (RA), but it is uncertain whether the…
Abstract Number: 413 • 2013 ACR/ARHP Annual Meeting
A Multiple Cause-Of-Death Study In Rheumatoid Arthritis
Frederico A. G. Pinheiro¹, Deborah C. C. Souza¹ and Emilia I. Sato², ¹Rheumatology, Universidade Federal de São Paulo, São Paulo, Brazil, ²Rheumatology Div/Dept of Med, Escola Paulista de Medicina - Universidade Federal de São Paulo, Sao Paulo, Brazil
Background/Purpose: Rheumatoid arthritis (RA) is the most common chronic inflammatory arthritis and has a high standardized mortality ratio when compared to general population. One of…
Abstract Number: 414 • 2013 ACR/ARHP Annual Meeting
High Prevalence Of Obesity Among Early and Established Rheumatoid Arthritis
Ines Colmegna¹, Maria Celia Bazan Bardales², Susan J. Bartlett³ and Carol A. Hitchon⁴, ¹Rheumatology, McGill University Health Centre, Montreal, QC, Canada, ²Rheumatology, McGill University, Montreal, QC, Canada, ³Clinical Epidemiology, McGill University, Montreal, QC, Canada, ⁴Rheumatology, University of Manitoba, Winnipeg, MB, Canada
Background/Purpose: Rheumatoid arthritis (RA) is characterized by early, accelerated atherosclerosis leading to increased disability, morbidity and mortality. Inflammation and traditional cardiovascular (CVD) risk factors contribute…
Abstract Number: 415 • 2013 ACR/ARHP Annual Meeting
Stability Of Carotid Intima Media Thickness and No Plaque Formation In Inflammatory Arthritis Patients On Biologics Over One Year
Stephanie O. Keeling¹, Asvina Bissonauth², Jeff Odenbach², Quazi Ibrahim³ and Michael Sean McMurtry⁴, ¹Division of Rheumatology, Department of Medicine, University of Alberta, Canada, Edmonton, AB, Canada, ²Medicine, University of Alberta, Edmonton, AB, Canada, ³Medicine, EPICORE, Edmonton, AB, Canada, ⁴Cardiology, University of Alberta, Edmonton, AB, Canada
Background/Purpose: Carotid intima media (cIMT) measurement is a validated surrogate measure of cardiovascular (CV) disease. Our aim was to evaluate baseline and follow-up cIMTs in…
Abstract Number: 416 • 2013 ACR/ARHP Annual Meeting
Changes In Body Composition On Two Different Glucocorticoid Regimens In Early RA: Experience From The Cobra-Light Trial
Nicole P.C. Konijn¹, Karin Britsemmer², Marieke M. ter Wee¹, Debby den Uyl¹, Birgit S. Blomjous¹, Maarten Boers^3,4, Dirkjan van Schaardenburg^5,6, Willem F. Lems^1,6 and Michael T Nurmohamed^5,7, ¹Rheumatology, VU University Medical Center, Amsterdam, Netherlands, ²Jan van Breemen Research Institute | Reade, Amsterdam, Netherlands, ³Epidemiology & Biostatistics, VU University Medical Center, Amsterdam, Netherlands, ⁴Deapartment of Epidemiology and Biostatistics, Jan van Breemen Research Institute/Reade, Amsterdam, Netherlands, ⁵VU University Medical Center, Amsterdam, Netherlands, ⁶Jan van Breemen Research Institute/Reade, Amsterdam, Netherlands, ⁷Rheumatology, Jan van Breemen Research Institute/Reade, Amsterdam, Netherlands
Background/Purpose: Prednisolone improves joint inflammation and disease severity in rheumatoid arthritis (RA), but is associated with multiple cardiovascular, metabolic and endocrine side effects and may…
Abstract Number: 417 • 2013 ACR/ARHP Annual Meeting
Consensus Statement On The Diagnosis and Management Of Comorbidity In Rheumatoid Arthritis
Cristina Lajas¹, José Luis Andreu², Alejandro Balsa³, Manuel Crespo⁴, Carlos M. Gonzalez⁵, Oscar Illera⁶, Juan A. Jover¹, Isabel Mateo⁷, Javier Orte⁸, Javier Rivera⁹, Jose M Rodriguez-Heredia¹⁰, Fredeswinda I. Romero¹¹, Juan A Martínez-López¹², Ana M. Ortiz¹³, Esther Toledano¹, Virginia Villaverde¹⁴, Estibaliz Loza¹⁵, Loreto Carmona^16,17 and Santos Castañeda¹⁸, ¹Rheumatology, Hospital Clínico San Carlos, Madrid, Spain, ²Rheumatology, Puerta de Hierro Universitary Hospital, Madrid, Spain, ³Rheumatology unit, La Paz University Hospital, Rheumatology, Madrid, Spain, ⁴Hospital universitario Severo Ochoa, Madrid, Spain, ⁵Rheumatology, Gregorio Marañon Hospital, Madrid, Spain, ⁶Rheumatology, Hospital Infanta Sofía, Madrid, Spain, ⁷Servicio De Reumatología, Hospital 12 De Octubre,, Madrid, Spain, ⁸Rheumatology, Hospital Universitario Ramón y Cajal, Madrid, Spain, ⁹Instituto Provincial de Rehabilitación, Madrid, Spain, ¹⁰Hospital Universitario de Getafe, Getafe, Spain, ¹¹Section for Autoimmune Diseases, Rheumatology, Jiménez Díaz Foundation University Hospital, Madrid, Spain, ¹²Rheumatology, Section for Autoimmune Diseases, Jiménez Díaz Foundation University Hospital, Madrid, Spain, ¹³Rheumatology, Hospital Universitario de La Princesa. IIS La Princesa, Madrid, Spain, ¹⁴Rheumatology, Hospital Universitario de Móstoles, Mostoles, Spain, ¹⁵Institu, Madrid, Spain, ¹⁶Institute for Musculoskeletal Health, Madrid, Spain, ¹⁷Health Sciences School, Universidad Camilo José Cela, Villanueva de la Cañada, Spain, ¹⁸Rheumatology, Hospital Universitario de La Princesa, IIS Princesa, Madrid, Spain
Background/Purpose: comorbidity in rheumatoid arthritis (RA) is very important because it might delay diagnosis and influence treatment decisions. It is usually related to complications, alters…
Abstract Number: 418 • 2013 ACR/ARHP Annual Meeting
Assessment Of Treatment Effect Over Insulin Resistance and Adipokines In Patients With Early Rheumatoid Arthritis: A 6 Months Longitudinal Observational Study
Sara Manrique-Arija¹, José Rioja², Pedro Valdivielso², María América López-Lasanta³, Pilar Espiño⁴, Inmaculada Ureña⁵, Francisco G. Jiménez-Núñez⁵, Carmen M. Romero-Barco⁵ and Antonio Fernández-Nebro¹, ¹Rheumatology, Hospital Carlos Haya. University of Malaga. IBIMA, Malaga, Spain, ²Department of Medicine. University of Malaga, Malaga, Spain, ³Rheumatology Research Group, Vall d'Hebron Hospital Research Institute, Barcelona, Spain, ⁴Hospital Carlos Haya. University of Malaga, Malaga, Spain, ⁵Rheumatology, Hospital Carlos Haya. University of Malaga, Malaga, Spain
Background/Purpose: To analyze treatment effects over insulin resistance (IR), adipokines, inflammatory cytokines and clinical and laboratory characteristics in patients with early rheumatoid arthritis (RA). Methods:…
Abstract Number: 419 • 2013 ACR/ARHP Annual Meeting
A Long Term Observation Of Rheumatoid Arthritis Who Developed Methotrexate Related Lymphoproliferative Disorders
Yukiko Kamogawa¹, Kyohei Nakamura², Ryu Watanabe², Tsuyoshi Shirai¹, Yoko Fujita³, Yuko Shirota⁴, Noriko Fukuhara¹, Hiroshi Fujii², Shinichiro Saito⁵, Tomonori Ishii² and Hideo Harigae², ¹Tohoku University, Sendai, Japan, ²Department of Hematology and Rheumatology, Tohoku University, Sendai, Japan, ³Department of Hematolgy and rheumatolgy, Tohoku University, Sendai, Japan, ⁴Department of Hematology and Rheumatolgy, Tohoku University, Sendai, Japan, ⁵Department of hematology and rheumatology, Tohoku University, Sendai, Japan
Background/Purpose: Methotrexate (MTX) has been increasingly administered by patients with rheumatoid arthritis (RA). In rare cases, we experience development of malignant lymphoma in patients treated…
Abstract Number: 382 • 2013 ACR/ARHP Annual Meeting
Effect Of Biologic Disease Modifiers On Cardiovascular Risk Of Patients With Rheumatoid Arthritis – 2 Years Prospective Cohort Study
Majed M. Khraishi¹ and Rana Aslanov², ¹Nexus Clinical Research, St John's, NF, Canada, ²Clinical Epidemiology Department, Faculty of Medicine, Memorial University of Newfoundland, St.John's, NF, Canada
Background/Purpose: People with RA have a higher risk for developing cardiovascular diseases than the general population. The pathogenic mechanisms in RA appear to be complex…
Abstract Number: 380 • 2013 ACR/ARHP Annual Meeting
Active Rheumatoid Arthritis Is An Independent Risk Factor Of Chronic Kidney Disease
Ryosuke Hanaoka^1,2, Kazuhiro Kurasawa³, Ayae Tanaka⁴ and Harutsugu Okada⁵, ¹Department of Rheumatology, Kamitsuga General Hospital, Kanuma, Japan, ²Department of Rheumatology, Kamitsuga General Hospital, Kanuma, Tochigi, Japan, ³Clinical Immunology, Dokkyo Medical University, Mibu-machi, Shimotsuga-gun, Tochigi-ken, Japan, ⁴Clinical Immunology, Dokkyo Medical University, Mibu, Tochigi, Japan, ⁵Clinical Immunology, Dokkyo Medical University, Mibu-machi, Tochigi-ken, Japan
Background/Purpose: Rheumatoid arthritis (RA) is a systemic inflammatory disease that affects not only joints but also many organs. RA causes vascular damages to contribute to…
Abstract Number: 381 • 2013 ACR/ARHP Annual Meeting
Coronary Endothelial Dysfunction Directly Measured By N13 Positron Emission Tomography (PET) Is Detected In Established Rheumatoid Arthritis (RA), But Not Early RA
OM Troum¹, OL Pimienta¹, B Hidalgo² and WA Hsueh³, ¹Keck School of Medicine, University of Southern California, Los Angeles, CA, ²Biostatistics, University of Alabama, Birmingham, AL, ³Medicine, Weill Cornell Medical College, Houston, TX
Background/Purpose: Rheumatoid arthritis (RA) is associated with increased risk of cardiovascular (CV) disease. The endothelium is a key regulator of vascular function. Subclinical CV disease and…
Abstract Number: 383 • 2013 ACR/ARHP Annual Meeting
Increased Incidence Of Low-Energy Fractures In Rheumatoid Arthritis Patients
Kristina Wiberg¹, Marie-Louise Öhman², Ulrika Bergström³ and Solbritt M. Rantapaa-Dahlqvist⁴, ¹Institution of Public Helath & Clinical Medicin, Rheumatology, Umeå University, Umeå, Sweden, ²Institution of Public Health & Clinical Medicin, Rheumatology, Umeå University, Umeå, Sweden, ³Department of Surgical and Perioperative Sciences, Umeå University, Umeå, Sweden, ⁴Rheumatology, Institution of Public health and clinical medicine/ Rheumatology, University of Umeå, Umeå, Sweden, Umea, Sweden
Background/Purpose: Patients with rheumatoid arthritis (RA) have increased development of osteoporosis. The fracture indicence is not well explored. The aim of this study was to…
Abstract Number: 384 • 2013 ACR/ARHP Annual Meeting
Carotid Artery Plaques Are Associated With Coronary Atherosclerosis In Patients With Inflammatory Joint Diseases Independent Of Several Cardiovascular Risk Calculators
Silvia Rollefstad¹, Eirik Ikdahl², Inge C. Olsen³, Tore K. Kvien^4,5, Anne S. Eirheim², Terje R. Pedersen^4,6 and Anne G. Semb², ¹Rhuematology, Diakonhjemmet Hospital, Oslo, Norway, ²Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ³Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ⁴Faculty of Medicine, University of Oslo, Oslo, Norway, ⁵Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ⁶Centre of Preventive Medicine, Oslo University Hospital-Ullevaal, Oslo, Norway
Background/Purpose: Patients with rheumatoid arthritis (RA) and carotid plaque (CP) have been shown to have increased risk of future acute coronary syndrome. We have established…
Abstract Number: 385 • 2013 ACR/ARHP Annual Meeting
Systemic Inflammation In Patients With Inflammatory Joint Disease Does Not Influence Statin Dose Needed To Obtain Low Density Lipoprotein Cholesterol Goal In Cardiovascular Prevention
Silvia Rollefstad¹, Eirik Ikdahl², Tore K. Kvien^3,4, Terje R. Pedersen^4,5, Ingar Holme⁶ and Anne G. Semb², ¹Rhuematology, Diakonhjemmet Hospital, Oslo, Norway, ²Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ³Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ⁴Faculty of Medicine, University of Oslo, Oslo, Norway, ⁵Centre of Preventive Medicine, Oslo University Hospital-Ullevaal, Oslo, Norway, ⁶Department of biostatistics, epidemiology and health economics, Oslo University Hospital-Ullevaal, Oslo, Norway
Background/Purpose: There is a lipid paradox in rheumatoid arthritis (RA): despite low lipids influenced by systemic inflammation, there is an increased risk of cardiovascular (CV)…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].